| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-06 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-05 |